The mechanism(s) of insulin resistance in non-insulin-dependent diabetes mellitus remains ill defined. The current studies sought to determine whether non-insulin-dependent diabetes mellitus is associated with (a) a delay in the rate of onset of insulin action, (b) impaired hepatic and extrahepatic kinetic responses to insulin, and (c) an alteration in the contribution of gluconeogenesis to hepatic glucose release. To answer these questions, glucose disappearance, glucose release, and the rate of incorporation of 14CO2 into glucose were measured during 0.5 and 1.0 mU/kg-1 per min-1 insulin infusions while glucose was clamped at approximately 95 mg/dl in diabetic and nondiabetic subjects. The absolute rate of disappearance was lower (P < 0.05) and the rate of increase slower (P < 0.05) in diabetic than nondiabetic subjects during both insulin infusions. In contrast, the rate of suppression of glucose release in response to a change in insulin did not differ in the diabetic and nondiabetic subjects during either the low (slope 30-240 min:0.02 +/- 0.01 vs 0.02 +/- 0.01) or high (0.02 +/- 0.00 vs 0.02 +/- 0.00) insulin infusions. However, the hepatic response to insulin was not entirely normal in the diabetic subjects. Both glucose release and the proportion of systemic glucose being derived from 14CO2 (an index of gluconeogenesis) was inappropriately high for the prevailing insulin concentration in the diabetic subjects. Thus non-insulin-dependent diabetes mellitus slows the rate-limiting step in insulin action in muscle but not liver and alters the relative contribution of gluconeogenesis and glycogenolysis to hepatic glucose release.
D Turk, A Alzaid, S Dinneen, K S Nair, R Rizza
Title and authors | Publication | Year |
---|---|---|
GC-MS-based Metabolomic Profiling of Thymoquinone in Streptozotocin-induced Diabetic Nephropathy in Rats
M Raish, A Ahmad, BL Jan, KM Alkharfy, K Mohsin, SR Ahamad, MA Ansari |
Natural Product Communications | 2017 |
Accurate Measurement of Postprandial Glucose Turnover: Why Is It Difficult and How Can It Be Done (Relatively) Simply?
RA Rizza, G Toffolo, C Cobelli |
Diabetes | 2016 |
Pioglitazone Increases Whole Body Insulin Sensitivity in Obese, Insulin-Resistant Rhesus Monkeys
E Tozzo, G Bhat, K Cheon, RC Camacho, H Ashida |
PloS one | 2015 |
The role of endothelial insulin signaling in the regulation of glucose metabolism
T Kubota, N Kubota, T Kadowaki |
Reviews in Endocrine and Metabolic Disorders | 2013 |
Use of dicarboxylic acids in type 2 diabetes: Dicarboxylic acids for type 2 diabetes
G Mingrone, L Castagneto-Gissey, K Macé |
British Journal of Clinical Pharmacology | 2013 |
The Metabolic Syndrome
S Devaraj, D Siegel, I Jialal |
The Metabolic Syndrome | 2011 |
The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action
EJ Barrett, EM Eggleston, AC Inyard, H Wang, G Li, W Chai, Z Liu |
Diabetologia | 2009 |
Pioglitazone Decreases Fasting and Postprandial Endogenous Glucose Production in Proportion to Decrease in Hepatic Triglyceride Content
B Ravikumar, J Gerrard, CD Man, MJ Firbank, A Lane, PT English, C Cobelli, R Taylor |
Diabetes | 2008 |
Increased Liver Fat, Impaired Insulin Clearance, and Hepatic and Adipose Tissue Insulin Resistance in Type 2 Diabetes
A Kotronen, L Juurinen, M Tiikkainen, S Vehkavaara, H Yki–Järvinen |
Gastroenterology | 2008 |
Whole-Body Proteolysis Rate Is Elevated in HIV-Associated Insulin Resistance
DN Reeds, WT Cade, BW Patterson, WG Powderly, S Klein, KE Yarasheski |
Diabetes | 2006 |
The CD200 Receptor Is a Novel and Potent Regulator of Murine and Human Mast Cell Function
HM Cherwinski, CA Murphy, BL Joyce, ME Bigler, YS Song, SM Zurawski, MM Moshrefi, DM Gorman, KL Miller, S Zhang, JD Sedgwick, JH Phillips |
Journal of immunology (Baltimore, Md. : 1950) | 2005 |
Assessment of Hepatic Glucose Metabolism by Indirect Calorimetry in Combination with a Non-Invasive Technique Using Naturally Enriched <sup>13</sup>C Glucose in Healthy Children and Adolescents
R Selz, FR Jornayvaz, L Tappy, V Woringer, GE Theintz |
Hormone Research | 2004 |
Tracer-determined glucose fluxes in health and type 2 diabetes: basal conditions
J Radziuk, S Pye |
Best Practice & Research Clinical Endocrinology & Metabolism | 2003 |
Does overnight normalization of plasma glucose by insulin infusion affect assessment of glucose metabolism in Type 2 diabetes?
P Staehr, K Hojlund, O Hother-Nielsen, JJ Holst, H Beck-Nielsen |
Diabetic Medicine | 2003 |
Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects
PE Carey, J Halliday, JE Snaar, PG Morris, R Taylor |
American journal of physiology. Endocrinology and metabolism | 2003 |
Hepatic glucose production: therapeutic target in type 2 diabetes?
P Staehr, O Hother-Nielsen, H Beck-Nielsen |
Diabetes, Obesity and Metabolism | 2002 |
Synthesis Rate of Muscle Proteins, Muscle Functions, and Amino Acid Kinetics in Type 2 Diabetes
P Halvatsiotis, KR Short, M Bigelow, KS Nair |
Diabetes | 2002 |
Regulation of endogenous glucose production after a mixed meal in type 2 diabetes
P Singhal, A Caumo, PE Carey, C Cobelli, R Taylor |
American journal of physiology. Endocrinology and metabolism | 2002 |
Assessment of Hepatic Insulin Action in Obese Type 2 Diabetic Patients
P Staehr, O Hother-Nielsen, K Levin, JJ Holst, H Beck-Nielsen |
Diabetes | 2001 |
Protein Metabolism in Clinically Stable Adult Cystic Fibrosis Patients With Abnormal Glucose Tolerance
A Moran, C Milla, R Ducret, KS Nair |
Diabetes | 2001 |
Reduced synthesis of muscle proteins in chronic renal failure
D Adey, R Kumar, JT McCarthy, KS Nair |
American journal of physiology. Endocrinology and metabolism | 2000 |
Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle
L Rossetti, AE Stenbit, W Chen, M Hu, N Barzilai, EB Katz, MJ Charron |
Journal of Clinical Investigation | 1999 |
Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle
L Rossetti, AE Stenbit, W Chen, M Hu, N Barzilai, EB Katz, MJ Charron |
Diabetes | 1999 |
Slower activation of insulin action in hypertension associated with obesity
G Biolo, G Toigo, B Ciocchi, R Situlin, G Guarnieri |
Journal of Hypertension | 1998 |
Insulin resistance in non-insulin-dependent diabetes mellitus
AA Alzaid |
Acta Diabetologica | 1996 |
The Lxl gene maps to mouse Chromosome 17 and codes for a protein that is homologous to glucose and polyspecific transmembrane transporters
N Schweifer, DP Barlow |
Mammalian Genome | 1996 |
Insulin resistance in non-insulin-dependent diabetes mellitus: A review
AA Alzaid |
Acta Diabetologica | 1996 |
Insulin Resistance
A Voll, J Kloster |
Acta Medica Scandinavica | 1957 |